Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712913 | SCV000229718 | uncertain significance | not provided | 2015-02-13 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000177786 | SCV000596744 | uncertain significance | not specified | 2017-01-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088748 | SCV000656312 | likely benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000177786 | SCV000843465 | likely benign | not specified | 2019-05-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712913 | SCV001793344 | likely benign | not provided | 2021-01-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29671837) |
Ambry Genetics | RCV002517721 | SCV003702728 | likely benign | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
University of Washington Center for Mendelian Genomics, |
RCV001291197 | SCV001479622 | likely pathogenic | Lissencephaly | no assertion criteria provided | research |